Asia Pacific Microtome Market Key Companies and SWOT Analysis by 2027

Asia Pacific Microtome Market is expected to reach US$ 40,160.6 thousand in 2027 from US$ 24,937.2 thousand in 2019. The market is expected to grow with a CAGR of 6.3% from 2020-2027.

The growth of the market is driven by factors such as the rising prevalence of cancer and the increasing adoption of digital pathology in developed economies. However, the Asia Pacific Microtome market is likely to have a negative impact due to lack of adoption in low-income countries.

Cancer is one of the significant causes of death across the globe, and its increasing prevalence is boosting the number of histopathology tests. A tissue pathology analysis is needed for the examination of a malignant tumour to predict the onset of cancer. According to data from the Global Cancer Observatory (WHO), expected 1,157,294 cancers were diagnosed in 2018 in India. Moreover, approximately 784,821 cancer deaths were recorded among the population in 2018 in the country. Increasing rates of cancer and growing knowledge concerning early diagnostic procedures are expected to boost the adoption rate of microtomes throughout the forecast period. Examination of biopsy tissues helps pathologists in discovering cancer type, stage, and the degree of disease spread.

Moreover, increasing awareness programs initiated by organizations such as Cancer Council Australia, Indian Council of Medical Research (ICMR), and Cancer Foundation of China for cancer screening are further driving the market growth. For instance, Cancer Council Australia has recommended mammography as a screening tool for the early detection of breast cancer. The screening program—Breast Screen Australia—allows women aged 50–74 to get free mammograms every two years. As per the Breast Screen Australia, over 1.8 million women aged 50–74 participated in the screening program in 2017–2018. The factors mentioned above are expected to drive the growth of the market for microtome during the coming years.

Moreover, the impact of the COVID-19 pandemic on the microtome market depends on the use of this device during surgeries. Domestic start-ups backed by international funding have already started witnessing back out from investors putting the development of the products in jeopardy. In these modern times, pharmaceutical companies are responding to the rapid challenges arising from a disruption in supply chains and the need to change business processes.

Asia Pacific Microtome Market Revenue and Forecast to 2027 (US$ Mn)

Asia Pacific Microtome Market– Market Segmentation

By Product

• Microtome Instruments
  • Rotary Microtomes
  • Cryostat Microtomes
  • Vibrating Microtomes
  • Other Microtome Instruments
• Microtome Accessories

By Technology

• Manual Microtomes
• Semi-automated Microtomes
• Fully Automated Microtomes

By End User

• Hospitals
• Clinical Laboratories
• Other End Users

By Country

• China
• Japan
• India
• Australia
• South Korea

Company Profiles

• PHC Holdings Corporation
• MEDITE Medical GmbH
• Leica Biosystems Nussloch GmbH (Danaher)
• Amos Scientific Pty Ltd
• SM Scientific Instruments Pvt. Ltd

Asia Pacific Microtome Report Scope